Rein Therapeutics Inc. (RNTX) has a consensus analyst rating of Hold, based on 1 analyst covering the stock. Of those, 0 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for RNTX is $6.00, representing a +268.1% upside from the current price of $1.63. Price targets range from a low of $6.00 to a high of $6.00.
